Here are 5 things we’ve learned so far from earnings season
admin Only about one-fifth of the S&P 500 have so far reported second-quarter results, but at…
Read MoreHealthcare
Do kids still get polio vaccines? Is polio airborne? What you need to know
The New York health department reported the country’s first case of polio in almost a…
Read MoreBavarian Nordic’s smallpox vaccine recommended for use against monkeypox in Europe
Bavarian Nordic A/S said Friday that it has received a positive opinion from the Committee…
Read MoreRoche backs 2022 outlook as profit climbs, boosted by diagnostics sales
Roche Holding AG said Thursday that profit for the first half of the year increased…
Read MoreBernstein still sees more pain ahead for stocks, until capitulation triggers bonafide rally next year
How bad is the mood out there right now? Try max bearish. So said Bank…
Read MoreNovartis sales and profit drop, but backs 2022 guidance
Corrections & Amplifications This headline was corrected at 0516 GMT becuase the core oper income…
Read MoreDow Jones Newswires: Novartis sales and profit drop, but backs 2022 guidance
The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from $2.89…
Read MoreCelcuity stock soars after hours on breakthrough therapy designation for cancer drug
Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S.…
Read MoreGE to name its power business GE Vernova after split off
GE Vernova will be the name of General Electric Co.’s power business when it splits…
Read More
Here are 5 things we’ve learned so far from earnings season
Only about one-fifth of the S&P 500 have so far reported second-quarter results, but at…
Read More